https://www.selleckchem.com/pr....oducts/marimastat.ht
Taken together, these results provide evidence of atheroprotective pro-resolving signalling through the RvD2-GPR18 axis.We could previously show that thromboxane A2 receptor (TP) activation inhibits the angiogenic capacity of human endothelial cells, but the underlying mechanisms remained unclear. Therefore, the aim of this study was to elucidate TP signal transduction pathways relevant to angiogenic sprouting of human endothelial cells. To clarify this matter, we used RNAi-mediated gene silencing as well as pharmacological inhibitio
Curtir
Comentario
Compartilhar
